Related Experiment Video
Updated: Sep 20, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Early Results of the New Pamira ICD Lead
Adrian Bystriansky1, Michael Ilan2, Ulrich Gerk3
1Department of Arrhythmology, Institute of Cardiovascular Diseases Banska Bystrica, Banska Bystrica, Slovakia.
Introduction:
A new implantable cardioverter-defibrillator (ICD) lead with a polyurethane cover added for improved long-term reliance was investigated in a post-market study.
Methods:
The prospective BIO|MASTER Pamira study is designed to evaluate the new Pamira ICD lead in patients undergoing de-novo ICD or cardiac resynchronization therapy (CRT-D) implantation. We report first data from implantation and 6-month follow-up.
Results:
Despite its slightly larger diameter, the lead demonstrated similar or improved handling during implantation compared to its predecessor without polyurethane cover.
Conclusion:
All results from implantation and short-term follow-up aligned with expectations. To show an improved reliance, long-term data will be required.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization II: Right Heart Catheterization

